Skip to the main content

Other

https://doi.org/10.24869/psyd.2026.303

Pharmacological alienation and the phenomenological self: SSRI use, bodily attunement, and phenomenological psychiatry

Toma Gruica ; “Dr. Franjo Tuđman” University of Defense and Security, Zagreb *

* Corresponding author.


Full text: english pdf 407 Kb

page 303-312

downloads: 0

cite


Abstract

Background: Phenomenological psychiatry, drawing on Heidegger, Merleau-Ponty, and Thomas Fuchs, particularly the concepts
of Stimmung, leibliche Resonanz, and being-in-the-world, initially engaged selective serotonin reuptake inhibitors (SSRIs) with
cautious optimism. Accumulating evidence now suggests their characteristic effects constitute a distinct form of ontological disturbance
not yet fully addressed in psychiatric practice or the philosophy of psychopharmacology.
Subjects and methods: This paper proceeds through textual and conceptual analysis rather than primary empirical research.
It draws on the empirical phenomenological studies of Teal (2009) and Bornäs and Sandell (2017), documenting first-person patient
accounts of SSRI treatment, alongside the philosophical analyses of Svenaeus (2006, 2007) on illness and homelikeness. These are read
against the biochemical critique of the serotonin hypothesis advanced by Moncrieff et al. (2022). The method is structural comparison:
identifying convergences between phenomenological accounts of disrupted bodily resonance and empirical findings undermining the
biochemical rationale for SSRIs, to determine whether both critiques support a shared conclusion.
Results: SSRIs appear to produce pharmacological alienation: a state in which the lived body loses resonant responsiveness to
the world without restoring the deep temporal and relational engagement constitutive of authentic being-in-the-world. Rather than
repairing disrupted attunement, SSRIs substitute a flattened mode of bodily experience for the responsiveness they were meant to
restore. This phenomenological finding is structurally convergent with Moncrieff et al.’s biochemical critique. Both lines of evidence
independently undermine confidence in SSRIs as agents that restore, rather than further disrupt, engagement with the world.
Conclusion: Phenomenological psychiatry, having extended initial charity to the SSRI paradigm, now has a principled basis
for rejecting it. The convergence of biochemical and phenomenological critique points to a deeper mismatch between pharmacological
mechanism and the ontological structure of depressive experience, not merely insufficient efficacy. A genuinely phenomenological
psychiatry would restore bodily resonance through metabolic, relational, and environmental means rather than pharmacological suppression
of attunement.

Keywords

SSRIs; phenomenological psychiatry; attunement; bodily resonance; pharmacological alienation

Hrčak ID:

353629

URI

https://hrcak.srce.hr/353629

Publication date:

17.11.2026.

Visits: 0 *